4//SEC Filing
CAVAZZA PAOLO 4
Accession 0001213900-17-013250
CIK 0001211583other
Filed
Dec 13, 7:00 PM ET
Accepted
Dec 14, 4:15 PM ET
Size
37.7 KB
Accession
0001213900-17-013250
Insider Transaction Report
Form 4
CAVAZZA PAOLO
10% Owner
Transactions
- Purchase
Common Stock
2017-12-12$8.50/sh+294,115$2,499,978→ 3,225,694 total
Cavazza Preta Martina
10% Owner
Transactions
- Purchase
Common Stock
2017-12-12$8.50/sh+294,115$2,499,978→ 3,225,694 total
Cavazza Francesca
10% Owner
Transactions
- Purchase
Common Stock
2017-12-12$8.50/sh+294,115$2,499,978→ 3,225,694 total
Cavazza Silvia
10% Owner
Transactions
- Purchase
Common Stock
2017-12-12$8.50/sh+294,115$2,499,978→ 3,225,694 total
SIGMA TAU FINANZIARIA SPA
10% Owner
Transactions
- Purchase
Common Stock
2017-12-12$8.50/sh+294,115$2,499,978→ 3,225,694 total
Cavazza Enrico
10% Owner
Transactions
- Purchase
Common Stock
2017-12-12$8.50/sh+294,115$2,499,978→ 3,225,694 total
Footnotes (2)
- [F1]Such shares were purchased in connection with a public offering by the issuer under a shelf registration statement, which closed on December 12, 2017.
- [F2]Dispositive power over the shares of common stock owned by Essetifin S.p.A. is shared by Enrico Cavazza, Silvia Cavazza, Francesca Cavazza, Martina Cavazza Preta and Paolo Cavazza. Each of Enrico Cavazza, Silvia Cavazza, Francesca Cavazza, Martina Cavazza Preta and Paolo Cavazza disclaims beneficial ownership of all shares of common stock held by Essetifin S.p.A. except to the extent of any pecuniary interest therein.
Issuer
FENNEC PHARMACEUTICALS INC.
CIK 0001211583
Entity typeother
Related Parties
1- filerCIK 0001163608
Filing Metadata
- Form type
- 4
- Filed
- Dec 13, 7:00 PM ET
- Accepted
- Dec 14, 4:15 PM ET
- Size
- 37.7 KB